As Death Rate Surges, Texas Asks Supreme Court to Let It Keep Denying Care to Pregnant Women

The state of Texas is asking the Supreme Court to allow it to continue denying emergency medical care to pregnant women, pretty please. The request, which the justices will consider at conference on Monday, September 30, comes on the heels of a new report that shows the state’s maternal mortality rate has spiked dramatically since … Read more

Justice Department asks Supreme Court to end abortion pill legal challenge that threatens widespread access

If lower court rulings were left in place, they “would impose grave harms on the government, mifepristone’s sponsors, women seeking medication abortions, and the public,” Prelogar added. Among other things, access to the pill by mail — which the FDA formally approved in 2021 — would be curtailed. Read more at NBC News  

Gov. Phil Murphy Warns ‘Everything Is On Table’ If Supreme Court Blocks Abortion Pill Access

Democratic New Jersey Gov. Phil Murphy on Wednesday said “everything is on the table” if the Supreme Court decides to outlaw the abortion drug mifepristone, which has been approved by the Food and Drug Administration, and warned Republicans who are moving toward restricting reproductive rights that they are “playing with fire.” Read more at Huffpost … Read more

Abortion pill battle threatens America’s ‘gold standard’ drug approval process

The plaintiffs in this case are questioning the FDA’s scientific process for evaluating the benefits of drugs. According to the Alliance for Hippocratic Medicine, if the appeals court rules in favor of the plaintiffs, its effects will extend beyond abortion access: A constant barrage of legal challenges to federal approval could discourage drugmakers from bringing … Read more

Mifepristone access – appeals court hearing – news round-up

Federal judges seem open to restricting access to mifepristone abortion pill A case like this is without precedent and, former FDA commissioners have warned in court-submitted briefs, could severely impair the agency. Pharmaceutical companies have also suggested that revoking mifepristone’s approval could discourage them from bringing new drugs to market. Read more at 19th News … Read more